Cancer News

Cancer immunotherapy clinical study approved for phase 1Jun 7, 2019
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
Study searches for families with gliomaMay 15, 2019
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
Ethical concerns of oncology trial-finding appsMay 13, 2019
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection
First-in-human trial shows promise in treating neuroblastomaApr 30, 2019
In a promising development, researchers released initial findings from the first two patients treated in a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma.
Colon cancer proteins, genes uncover potential treatmentsApr 25, 2019
Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view of the tumor that points at novel cancer biological mechanisms and possible new therapeutic strategies.
Shortages of pediatric cancer medicines threaten outcomesMar 4, 2019
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country.
Cancer Prevention & Research Institute of Texas awards grantsFeb 22, 2019
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
Stand Up To Cancer Dream Team tackles T-cell lymphomaJan 29, 2019
Stand Up To Cancer announced at the annual SU2C Scientific Summit the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma.
Discovery explains breast cancer cells’ ability to adapt, surviveJan 28, 2019
A team led by researchers at Baylor College of Medicine has discovered that breast cancer cells can shift between two forms of the cell surface molecule CD44, CD44s and CD44v.
Global grants aim to help scientists understand tumor behaviorJan 23, 2019
A multidisciplinary, international team of scientists has been awarded Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.